What Is HIV-Related Hypogonadism?
HIV-related hypogonadism is testosterone deficiency caused by HIV infection and its effects on the hormone production system. It affects roughly 30% of men living with HIV, even in the modern treatment era1.
In about 75% of cases, the problem starts in the brain1. HIV triggers chronic inflammation that disrupts the hypothalamic-pituitary-gonadal (HPG) axis — the communication loop between your brain and testes. Your hypothalamus and pituitary gland stop sending the right signals, so your testes produce less testosterone. This is called secondary hypogonadism. The remaining cases involve direct testicular damage from opportunistic infections or the virus itself.
Key Takeaways
About 30% of men on antiretroviral therapy have low testosterone, primarily from HPG axis suppression rather than testicular failure. Free testosterone is the most reliable diagnostic marker due to SHBG variability from ART drugs. Optimizing HIV treatment often improves testosterone naturally, but TRT is effective when deficiency persists.
- Diagnosis: Requires two morning lab draws showing low free testosterone
- Monitoring: CD4 and viral load tracked closely if starting TRT
Signs and Symptoms
Low testosterone symptoms in HIV overlap heavily with HIV disease symptoms, making diagnosis challenging without lab confirmation.
Fatigue and Low Energy
Persistent exhaustion that doesn't improve with rest or viral suppression.
Erectile Dysfunction and Low Libido
Difficulty achieving or maintaining erections and reduced sexual desire.
Muscle Weakness and Wasting
Progressive loss of lean body mass and strength despite adequate nutrition.
Mood Changes and Depression
Increased irritability, low mood, and difficulty concentrating.
Severity varies. Some men experience mild fatigue and reduced libido. Others develop significant muscle wasting that compounds HIV-related frailty.
The challenge is separating testosterone deficiency from HIV disease progression. Both cause fatigue, weight loss, and mood changes. Many men assume their symptoms are just part of living with HIV when low testosterone is actually a treatable contributor. That's why lab testing is essential — you can't diagnose hypogonadism on symptoms alone in this population.
Low testosterone also worsens frailty in men living with HIV2. The combination of viral inflammation, aging, and hormone deficiency creates a faster decline in physical function than HIV or low testosterone would cause separately.
Hypogonadism is a clinical condition characterized by abnormally low testosterone production, resulting in deficient hormone levels that affect sexual function, muscle mass, mood, and energy metabolism in men.
Why It Happens
HPG Axis Disruption
HIV infection triggers inflammatory cytokines that suppress the hypothalamus and pituitary. Your brain produces low or normal levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), so your testes never receive the signal to make testosterone. This accounts for 75% of hypogonadism cases in men with HIV1.
Chronic Inflammation
Elevated tumor necrosis factor and interleukin-1 from persistent immune activation directly suppress testicular steroidogenesis — the cellular process that converts cholesterol into testosterone1. Your testes have the signal but can't respond properly.
ART and Medication Effects
Some antiretroviral drugs raise sex hormone-binding globulin (SHBG), the protein that binds testosterone in your bloodstream. Efavirenz, for example, can produce estrogenic effects and spike SHBG to 170 nmol/L or higher, dropping free testosterone even when total testosterone looks normal1.
Metabolic Factors
Obesity, insulin resistance, and lipodystrophy lower both total and free testosterone. Fat tissue converts testosterone to estrogen through aromatase activity. Many men with HIV develop metabolic syndrome from a combination of ART, aging, and chronic inflammation.
Primary hypogonadism — direct testicular failure with elevated LH and FSH — occurs in 14-37% of cases2. Opportunistic infections like cytomegalovirus or toxoplasmosis can damage testicular tissue directly, though this is rare in the modern ART era.
The relationship runs both ways. Low testosterone worsens HIV-related muscle wasting and frailty, creating a feedback loop where poor health drives testosterone lower, which then worsens physical decline.
How It's Diagnosed
Diagnosis requires lab confirmation. Symptoms alone aren't enough because fatigue, erectile dysfunction, and muscle loss occur in HIV disease regardless of testosterone status.
The key tests are total testosterone, free testosterone, LH, and FSH. Total testosterone below 11 nmol/L (roughly 317 ng/dL) is considered low in most clinical contexts1. But men with HIV often have elevated SHBG from antiretroviral therapy, which artificially raises total testosterone while free testosterone — the biologically active form — remains low.
That's why free testosterone is the more reliable marker. Calculated free testosterone below 60 pmol/L suggests deficiency when total testosterone is borderline.
| Test | Normal Range | Low/Abnormal | Interpretation |
|---|---|---|---|
| Total Testosterone | 11-35 nmol/L | <11 nmol/L | Confirms deficiency if free T also low |
| Free Testosterone | 60-200 pmol/L | <60 pmol/L | More reliable in HIV due to SHBG variability |
| LH | 1.5-9.3 IU/L | Normal/Low with low T | Suggests secondary hypogonadism |
| LH | 1.5-9.3 IU/L | Elevated with low T | Suggests primary hypogonadism |
| FSH | 1.4-18.1 IU/L | Elevated with low T | Confirms testicular failure |
LH and FSH results distinguish secondary from primary hypogonadism. Normal or low LH with low testosterone points to HPG axis suppression — the brain isn't signaling properly. Elevated LH with low testosterone means your testes are getting the signal but can't respond, indicating testicular damage.
Timing matters. Morning samples between 7-11 AM capture peak testosterone levels. Two separate low readings confirm the diagnosis. Your doctor should also evaluate for reversible causes: poor viral control, specific ART drugs, obesity, and untreated comorbidities like hepatitis C or diabetes.
Treatment and Management
Optimize ART
Achieving viral suppression improves testosterone naturally in many cases. If you're on efavirenz and have high SHBG, switching to a different regimen can restore free testosterone without hormone therapy.
Weight Management and Metabolic Health
Losing excess body fat raises testosterone by reducing aromatase activity. Treating insulin resistance and metabolic syndrome addresses root causes of low testosterone in HIV.
Resistance Exercise
Progressive strength training preserves muscle mass and may modestly improve testosterone. It also counters HIV-related frailty directly, regardless of hormone levels.
Sleep and Stress Management
Poor sleep suppresses testosterone production. Chronic stress elevates cortisol, which antagonizes testosterone signaling. Target 7-9 hours nightly and address underlying sleep disorders.
Cardiovascular Activity
Moderate aerobic exercise improves insulin sensitivity and supports metabolic health. Avoid overtraining — excessive endurance work can suppress testosterone further.
TRT Monitoring
If testosterone replacement is initiated, monitor CD4 count, viral load, and cardiovascular risk markers. TRT requires coordination with your HIV specialist to ensure it doesn't interfere with antiretroviral therapy.
Testosterone replacement therapy improves libido, erectile function, and muscle mass in hypogonadal men with HIV1. It's straightforward in primary hypogonadism cases where LH is elevated. Secondary hypogonadism requires more caution — you need to rule out reversible causes first.
The timeline is gradual. Most men notice initial improvements in energy and mood within 3-6 weeks. Sexual function and muscle mass take 3-6 months of consistent treatment. Erectile dysfunction medications work better once testosterone is normalized3.
TRT in HIV is off-label but well-supported by clinical experience. The main concern is cardiovascular risk, which is already elevated in men with HIV. Your provider will monitor hematocrit, lipids, and blood pressure closely. CD4 count and viral load should remain stable on TRT, but regular monitoring ensures no unexpected interactions with your ART regimen.
Many cases of functional hypogonadism improve with better HIV control, ART optimization, and metabolic management. TRT is effective when hormone deficiency persists despite addressing reversible factors. Work with a provider experienced in both HIV care and hormone therapy to navigate the decision.